NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hayden Royal, LLC | 20,642 | $91,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 173,202 | $762,000 | 0.01% |
| SG3 Management, LLC | 50,000 | $220,000 | 0.01% |
| Ameritas Investment Partners, Inc. | 378 | $2,000 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 9,817 | $43,000 | 0.00% |
| UBS Group AG | 2,841 | $13,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 3,926 | $17,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11,642 | $51,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 13,762 | $61,000 | 0.00% |
| NORTHERN TRUST CORP | 78,993 | $348,000 | 0.00% |